UCB adopts Enterprise version of NextBio platform

NextBio, developer of an innovative software platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a license agreement with global biopharmaceutical company UCB, for NextBio Enterprise. NextBio Enterprise offers life sciences organizations unique tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.

“UCB is one of the leading biopharmaceutical companies, with operations in Europe, the United States and Asia”

“UCB is one of the leading biopharmaceutical companies, with operations in Europe, the United States and Asia,” said Saeid Akhtari, co-founder and Chief Executive Officer of NextBio. “We are very pleased that they are adopting the Enterprise version of the NextBio platform as an integral part of their research and development efforts. UCB’s adoption of NextBio Enterprise will enable its scientists to gain unique insights from data created by diverse high-throughput technologies.”